Baillie Gifford & CO Tandem Diabetes Care Inc Transaction History

Baillie Gifford & CO

  • $128 Billion
  • Q3 2025

A detailed history of Baillie Gifford & CO transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 1,120,595 shares of TNDM stock, worth $16.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,120,595
Previous 1,125,728 0.46%
Holding current value
$16.3 Million
Previous $21 Million 35.17%
% of portfolio
0.01%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025
SELL
$10.12 - $17.24 $51,945 - $88,492
-5,133 Reduced 0.46%
1,120,595 $13.6 Million
Q2 2025

Aug 06, 2025
BUY
$16.35 - $23.52 $6.43 Million - $9.25 Million
393,154 Added 53.67%
1,125,728 $21 Million
Q1 2025

May 07, 2025
SELL
$17.89 - $37.53 $242,141 - $507,968
-13,535 Reduced 1.81%
732,574 $14 Million
Q4 2024

Jan 31, 2025
BUY
$27.34 - $41.78 $14.3 Million - $21.9 Million
523,843 Added 235.68%
746,109 $26.9 Million
Q3 2024

Nov 05, 2024
SELL
$35.21 - $47.3 $4,225 - $5,676
-120 Reduced 0.05%
222,266 $9.42 Million
Q2 2024

Jul 25, 2024
SELL
$30.43 - $53.43 $1.14 Million - $1.99 Million
-37,311 Reduced 14.37%
222,386 $8.96 Million
Q1 2024

May 01, 2024
SELL
$22.09 - $35.41 $65,077 - $104,317
-2,946 Reduced 1.12%
259,697 $9.2 Million
Q4 2023

Jan 26, 2024
SELL
$14.28 - $31.03 $1,613 - $3,506
-113 Reduced 0.04%
262,643 $7.77 Million
Q2 2023

Jul 28, 2023
SELL
$24.18 - $42.46 $4,521 - $7,940
-187 Reduced 0.07%
262,756 $6.45 Million
Q1 2023

May 03, 2023
SELL
$35.86 - $46.5 $5,056 - $6,556
-141 Reduced 0.05%
262,943 $10.7 Million
Q3 2022

Oct 27, 2022
SELL
$43.76 - $68.97 $1.89 Million - $2.98 Million
-43,139 Reduced 14.09%
263,084 $12.6 Million
Q2 2022

Aug 08, 2022
SELL
$53.22 - $123.09 $1.47 Million - $3.39 Million
-27,578 Reduced 8.26%
306,223 $18.1 Million
Q1 2022

May 05, 2022
SELL
$101.89 - $150.09 $2.36 Million - $3.47 Million
-23,151 Reduced 6.49%
333,801 $38.8 Million
Q4 2021

Jan 20, 2022
BUY
$118.18 - $153.21 $1.17 Million - $1.52 Million
9,900 Added 2.85%
356,952 $53.7 Million
Q3 2021

Oct 19, 2021
BUY
$93.51 - $129.4 $11,875 - $16,433
127 Added 0.04%
347,052 $41.4 Million
Q2 2021

Aug 02, 2021
BUY
$77.0 - $100.19 $12,936 - $16,831
168 Added 0.05%
346,925 $33.8 Million
Q1 2021

May 06, 2021
BUY
$81.28 - $104.34 $4.17 Million - $5.35 Million
51,312 Added 17.37%
346,757 $30.6 Million
Q4 2020

Feb 10, 2021
BUY
$86.4 - $121.75 $15,206 - $21,428
176 Added 0.06%
295,445 $28.3 Million
Q2 2020

Aug 12, 2020
SELL
$60.05 - $98.92 $8.37 Million - $13.8 Million
-139,431 Reduced 32.08%
295,269 $29.2 Million
Q3 2018

Nov 13, 2018
BUY
$21.39 - $51.17 $9.3 Million - $22.2 Million
434,700 New
434,700 $18.6 Million

Others Institutions Holding TNDM

# of Institutions
299
Shares Held
79.6M
Call Options Held
2.87M
Put Options Held
134K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $937M
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email